Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025

Verrica Pharmaceuticals Inc VRCA:

• VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT WITH TORII PHARMACEUTICAL TO LAUNCH GLOBAL PIVOTAL PHASE 3 CLINICAL TRIAL TO STUDY YCANTH® FOR THE TREATMENT OF COMMON WARTS

• VERRICA PHARMACEUTICALS INC - TO RECEIVE $8 MILLION MILESTONE PAYMENT IN JULY 2025

• VERRICA PHARMACEUTICALS INC - TO RECEIVE $10 MILLION MILESTONE PAYMENT UPON YCANTH APPROVAL IN JAPAN

• VERRICA PHARMACEUTICALS INC - TORII TO FUND FIRST $40 MILLION OF GLOBAL STUDY COSTS